Capital International Investors’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
2021
Q2
$5.63M Hold
2021
Q1
$7.02M Hold
2020
Q4
$7.12M Hold
2020
Q3
$10.5M Hold
2020
Q2
$13.2M Hold
2020
Q1
$3.59M Buy
2019
Q4
$752K Hold
2019
Q3
$947K Hold
2019
Q2
$2.52M Buy
2019
Q1
$1.69M Hold
2018
Q4
$2.27M Hold
2018
Q3
$5.34M Buy